Andrea F. Wainer - May 2, 2023 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role: EXECUTIVE VICE PRESIDENT
Signature: /s/ Andrea F. Wainer by Jessica H. Paik, Attorney-in-Fact
Stock symbol: ABT
Transactions as of: May 2, 2023
Transactions value $: -$522,850
Form type: 4
Date filed: 5/3/2023, 07:09 PM
Previous filing: Mar 2, 2023
Next filing: Aug 10, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABT	Common shares without par value	Options Exercise	$387K	+8.23K	+11.68%	$47.00	78.7K	May 2, 2023	Direct
transaction	ABT	Common shares without par value	Sale	-$909K	-8.23K	-10.46%	$110.56	70.4K	May 2, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABT	Option (right to buy)	Options Exercise	$0	-8.23K	-100%	$0.00^*	0	May 2, 2023	Common Shares	8.23K	$47.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.5501 to $110.562, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2	Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.5501 to $110.562, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.